Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("INGLE, James N")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 100

  • Page / 4
Export

Selection :

  • and

Pharmacogenomics of Tamoxifen and Aromatase InhibitorsINGLE, James N.Cancer. 2008, Vol 112, Num 3, pp 695-699, issn 0008-543X, 5 p., SUPConference Paper

Overview of adjuvant trials of aromatase inhibitors in early breast cancerINGLE, James N.Steroids. 2011, Vol 76, Num 8, pp 765-767, issn 0039-128X, 3 p.Conference Paper

Adjuvant endocrine therapy for postmenopausal women with early breast cancerINGLE, James N.Clinical cancer research. 2006, Vol 12, Num 3, issn 1078-0432, 1031s-1036s, 2Conference Paper

Sequencing of endocrine therapy in postmenopausal women with advanced breast cancerINGLE, James N.Clinical cancer research. 2004, Vol 10, Num 1, pp 362s-367s, issn 1078-0432, 2Conference Paper

Decision making in adjuvant trials in breast cancer : the NCIC CTG MA.17 trial as an examplePATER, Joseph; DONGSHENG TU; SHEPHERD, Lois et al.Breast cancer research and treatment. 2008, Vol 108, Num 2, pp 265-269, issn 0167-6806, 5 p.Article

Aromatase inhibitors for therapy of advanced breast cancerINGLE, James N; SUMAN, Vera J.Journal of steroid biochemistry and molecular biology. 2005, Vol 95, Num 1-5, pp 113-119, issn 0960-0760, 7 p.Conference Paper

Differential gene expression of TGF-β family members and osteopontin in breast tumor tissue: Analysis by real-time quantitative PCRREINHOLZ, Monica M; ITURRIA, Stephen J; INGLE, James N et al.Breast cancer research and treatment. 2002, Vol 74, Num 3, pp 255-269, issn 0167-6806Article

Tissue composition of mammographically dense and non-dense breast tissueGHOSH, Karthik; BRANDT, Kathleen R; INGLE, James N et al.Breast cancer research and treatment. 2012, Vol 131, Num 1, pp 267-275, issn 0167-6806, 9 p.Article

A Degenerate HLA-DR Epitope Pool of HER-2/neu Reveals a Novel In vivo Immunodominant Epitope, HER-2/neu88-102KARYAMPUDI, Lavakumar; FORMICOLA, Courtney; HARTMANN, Lynn C et al.Clinical cancer research (Print). 2010, Vol 16, Num 3, pp 825-834, issn 1078-0432, 10 p.Article

Identification of a broad coverage HLA-DR degenerate epitope pool derived from carcinoembryonic antigenKARYAMPUDI, Lavakumar; KRCO, Christopher J; DISIS, Mary L et al.Cancer immunology and immunotherapy. 2010, Vol 59, Num 1, pp 161-171, issn 0340-7004, 11 p.Article

Immune-Induced Epithelial to Mesenchymal Transition In vivo Generates Breast Cancer Stem CellsSANTISTEBAN, Marta; REIMAN, Jennifer M; RADISKY, Derek C et al.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 7, pp 2887-2895, issn 0008-5472, 9 p.Article

Cardiac Safety Analysis of Doxorubicin and Cyclophosphamide Followed by Paclitaxel With or Without Trastuzumab in the North Central Cancer Treatment Group N9831 Adjuvant Breast Cancer TrialPEREZ, Edith A; SUMAN, Vera J; WINER, Eric P et al.Journal of clinical oncology. 2008, Vol 26, Num 8, pp 1231-1238, issn 0732-183X, 8 p.Article

Sequenced compared with simultaneous anthracycline and cyclophosphamide in high-risk stage I and II breast cancer : Final analysis from INT-0137 (s9313)LINDEN, Hannah M; HASKELL, Charles M; MARTINO, Silvana et al.Journal of clinical oncology. 2007, Vol 25, Num 6, pp 656-661, issn 0732-183X, 6 p.Article

Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer : Updated findings from NCIC CTG MA.17GOSS, Paul E; INGLE, James N; LIVINGSTON, Robert B et al.Journal of the National Cancer Institute. 2005, Vol 97, Num 17, pp 1262-1271, issn 0027-8874, 10 p.Article

Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashesGOETZ, Matthew P; RAE, James M; DESTA, Zeruesenay et al.Journal of clinical oncology. 2005, Vol 23, Num 36, pp 9312-9318, issn 0732-183X, 7 p.Article

Structural analysis of the 17q22-23 amplicon identifies several independent targets of amplification in breast cancer cell lines and tumorsWU, Guo-Jun; SINCLAIR, Colleen; HINSON, Shannon et al.Cancer research (Baltimore). 2001, Vol 61, Num 13, pp 4951-4955, issn 0008-5472Article

Novel Methylated Biomarkers and a Robust Assay to Detect Circulating Tumor DNA in Metastatic Breast CancerFACKLER, Mary Jo; LOPEZ BUJANDA, Zoila; LYMAN, Jaclyn P et al.Cancer research (Chicago, Ill.). 2014, Vol 74, Num 8, pp 2160-2170, issn 0008-5472, 11 p.Article

Exemestane Versus Anastrozole in Postmenopausal Women With Early Breast Cancer: NCIC CTG MA.27—A Randomized Controlled Phase III TrialGOSS, Paul E; INGLE, James N; D'SOUZA, David P et al.Journal of clinical oncology. 2013, Vol 31, Num 11, pp 1398-1404, issn 0732-183X, 7 p.Article

Aromatase immunoreactivity is increased in mammographically dense regions of the breastVACHON, Celine M; SASANO, Hironobu; SCOTT, Christopher G et al.Breast cancer research and treatment. 2011, Vol 125, Num 1, pp 243-252, issn 0167-6806, 10 p.Article

Exemestane for Breast-Cancer Prevention in Postmenopausal WomenGOSS, Paul E; INGLE, James N; WINQUIST, Eric et al.The New England journal of medicine. 2011, Vol 364, Num 25, pp 2381-2391, issn 0028-4793, 11 p.Article

TGFβ/TNFα-Mediated Epithelial―Mesenchymal Transition Generates Breast Cancer Stem Cells with a Claudin-Low PhenotypeASIEDU, Michael K; INGLE, James N; BEHRENS, Marshall D et al.Cancer research (Chicago, Ill.). 2011, Vol 71, Num 13, pp 4707-4719, issn 0008-5472, 13 p.Article

p53 Expression in Node-Positive Breast Cancer Patients: Results from the Cancer and Leukemia Group B 9344 Trial (159905)LARA, Jonathan F; THOR, Ann D; CRAIG HENDERSON, I et al.Clinical cancer research (Print). 2011, Vol 17, Num 15, pp 5170-5178, issn 1078-0432, 9 p.Article

Functional Genetic Polymorphisms in the Aromatase Gene CYP19 Vary the Response of Breast Cancer Patients to Neoadjuvant Therapy with Aromatase InhibitorsLIEWEI WANG; ELLSWORTH, Katarzyna A; RAVI, Saranya et al.Cancer research (Chicago, Ill.). 2010, Vol 70, Num 1, pp 319-328, issn 0008-5472, 10 p.Article

HER2 testing by local, central, and reference laboratories in specimens from the north central cancer treatment group N9831 intergroup adjuvant trialPEREZ, Edith A; SUMAN, Vera J; DAVIDSON, Nancy E et al.Journal of clinical oncology. 2006, Vol 24, Num 19, pp 3032-3038, issn 0732-183X, 7 p.Article

Efficacy of radiotherapy for ovarian ablation: Results of a breast intergroup studyHUGHES, Lorie L; GRAY, Robert J; SOLIN, Lawrence J et al.Cancer. 2004, Vol 101, Num 5, pp 969-972, issn 0008-543X, 4 p.Article

  • Page / 4